Cargando…

Higher CSF sTREM2 and microglia activation are associated with slower rates of beta‐amyloid accumulation

Microglia activation is the brain's major immune response to amyloid plaques in Alzheimer's disease (AD). Both cerebrospinal fluid (CSF) levels of soluble TREM2 (sTREM2), a biomarker of microglia activation, and microglia PET are increased in AD; however, whether an increase in these bioma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ewers, Michael, Biechele, Gloria, Suárez‐Calvet, Marc, Sacher, Christian, Blume, Tanja, Morenas‐Rodriguez, Estrella, Deming, Yuetiva, Piccio, Laura, Cruchaga, Carlos, Kleinberger, Gernot, Shaw, Leslie, Trojanowski, John Q, Herms, Jochen, Dichgans, Martin, Brendel, Matthias, Haass, Christian, Franzmeier, Nicolai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507349/ https://www.ncbi.nlm.nih.gov/pubmed/32790063 http://dx.doi.org/10.15252/emmm.202012308

Ejemplares similares

Early increase of CSF sTREM2 in Alzheimer’s disease is associated with tau related-neurodegeneration but not with amyloid-β pathology
por: Suárez-Calvet, Marc, et al.
Publicado: (2019)

Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration
por: Franzmeier, Nicolai, et al.
Publicado: (2020)

CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline
por: Suárez‐Calvet, Marc, et al.
Publicado: (2018)

sTREM2 is associated with amyloid‐related p‐tau increases and glucose hypermetabolism in Alzheimer's disease
por: Biel, Davina, et al.
Publicado: (2023)

Increase of TREM2 during Aging of an Alzheimer’s Disease Mouse Model Is Paralleled by Microglial Activation and Amyloidosis
por: Brendel, Matthias, et al.
Publicado: (2017)

The APOE ε4 genotype modulates CSF YKL-40 levels and their structural brain correlates in the continuum of Alzheimer's disease but not those of sTREM2
por: Gispert, Juan Domingo, et al.
Publicado: (2016)

sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers
por: Suárez‐Calvet, Marc, et al.
Publicado: (2016)

The Trem2 R47H Alzheimer’s risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans
por: Xiang, Xianyuan, et al.
Publicado: (2018)

Neuroinflammatory CSF biomarkers MIF, sTREM1, and sTREM2 show dynamic expression profiles in Alzheimer’s disease
por: Hok-A-Hin, Yanaika S., et al.
Publicado: (2023)

sTREM-1 is a specific biomarker of TREM-1 pathway activation
por: Jolly, Lucie, et al.
Publicado: (2021)

An Alzheimer‐associated TREM2 variant occurs at the ADAM cleavage site and affects shedding and phagocytic function
por: Schlepckow, Kai, et al.
Publicado: (2017)

Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational study
por: Morenas-Rodríguez, Estrella, et al.
Publicado: (2022)

TREM2 deficiency reduces the efficacy of immunotherapeutic amyloid clearance
por: Xiang, Xianyuan, et al.
Publicado: (2016)

The sTREM2 Concentrations in the Blood: A Marker of Neurodegeneration?
por: Ferri, Evelyn, et al.
Publicado: (2021)

CSF glial biomarkers YKL40 and sTREM2 are associated with longitudinal volume and diffusivity changes in cognitively unimpaired individuals
por: Falcon, Carles, et al.
Publicado: (2019)

Leishmania infantum Induces the Release of sTREM-1 in Visceral Leishmaniasis
por: Bomfim, Lays G. S., et al.
Publicado: (2017)

Dynamic Monitoring of sTREM-1 and Other Biomarkers in Acute Cholangitis
por: Jiang, Jiahui, et al.
Publicado: (2020)

Neuroinflammation Is Associated with GFAP and sTREM2 Levels in Multiple Sclerosis
por: Azzolini, Federica, et al.
Publicado: (2022)

sTREM-1 as a Prognostic Marker of Postoperative Complications in Cardiac Surgery
por: Golovkin, A. S., et al.
Publicado: (2012)

Diagnostic value of sTREM-1 and procalcitonin levels in the early diagnosis of sepsis
por: Aksaray, Sebahat, et al.
Publicado: (2017)

Glial activation is moderated by sex in response to amyloidosis but not to tau pathology in mouse models of neurodegenerative diseases
por: Biechele, Gloria, et al.
Publicado: (2020)

Association of decreased serum sTREM-1 level with the severity of coronary artery disease: Inhibitory effect of sTREM-1 on TNF-α- and oxLDL-induced inflammatory reactions in endothelial cells
por: Dai, Daopeng, et al.
Publicado: (2016)

CSF sTREM2: marking the tipping point between preclinical AD and dementia?
por: Schindler, Suzanne E, et al.
Publicado: (2016)

Diagnostic and Prognostic Value of IL-6 and sTREM-1 in SIRS and Sepsis in Children
por: Smok, Beata, et al.
Publicado: (2020)

Dynamic changes of CSF sTREM2 in preclinical Alzheimer’s disease: the CABLE study
por: Ma, Ling-Zhi, et al.
Publicado: (2020)

Plasma sTREM2: a potential marker of cerebrovascular injury in neurodegenerative disorders
por: Rodriguez-Vieitez, Elena, et al.
Publicado: (2021)

sTREM-1 and TNF-α levels are associated with the clinical outcome of leprosy patients
por: Bezerra-Santos, Márcio, et al.
Publicado: (2023)

African Americans Have Differences in CSF Soluble TREM2 and Associated Genetic Variants
por: Schindler, Suzanne E., et al.
Publicado: (2021)

KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimer’s disease
por: Neitzel, Julia, et al.
Publicado: (2021)

Urine sTREM-1 assessment in diagnosing sepsis and sepsis-related acute kidney injury
por: Derive, Marc, et al.
Publicado: (2011)

Role of sTREM-1 in predicting mortality of infection: a systematic review and meta-analysis
por: Su, Longxiang, et al.
Publicado: (2016)

Cerebrospinal fluid sTREM2 in Alzheimer’s disease: comparisons between clinical presentation and AT classification
por: Knapskog, Anne-Brita, et al.
Publicado: (2020)

Evaluation of sTREM1 and suPAR Biomarkers as Diagnostic and Prognostic Predictors in Sepsis Patients
por: Nasr El-Din, Asmaa, et al.
Publicado: (2021)

CSF sTREM2 in neurological diseases: a two-sample Mendelian randomization study
por: Dong, Ming-Hao, et al.
Publicado: (2022)

sTREM2 is a plasma biomarker for human NASH and promotes hepatocyte lipid accumulation
por: Kothari, Vishal, et al.
Publicado: (2023)

sTREM2 is associated with attenuated tau aggregate accumulation in the presence of amyloid-β pathology
por: Nabizadeh, Fardin
Publicado: (2023)

Validation of sTREM-1 and IL-6 based algorithms for outcome prediction of COVID-19
por: Van Singer, Mathias, et al.
Publicado: (2023)

Loss of TREM2 function increases amyloid seeding but reduces plaque associated ApoE
por: Parhizkar, Samira, et al.
Publicado: (2019)

sTREM-1 is not suitable to discriminate survivors and nonsurvivors in surgical patients with severe sepsis or septic shock
por: Bopp, C, et al.
Publicado: (2007)

Correction: Role of sTREM-1 in predicting mortality of infection: a systematic review and meta-analysis
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_eishi9ms7irq0p7j4m5uqgm2r4